Duke's stage, lymph node metastasis, special pathology, and other factors were suggested as possible parameters related to K-ras mutations in previous studies, but no correlation has been achieved yet[22,23]. Here, KRAS is linked to metastatic malignant neoplasm in the lymph nodes.